The NICE Implementation Collaborative (NIC) has published a consensus statement on the use of Novel Oral Anticoagulants (NOACs) in non-valvular atrial fibrillation.
This consensus report was developed following a workshop meeting, where health care professionals and patient group representatives discussed barriers to use of the non-Vitamin K antagonist oral anticoagulants (NOACs, previously called new or novel oral anticoagulants) for reducing stroke risk in non-valvular atrial fibrillation, and how these barriers might be overcome locally to facilitate appropriate use of the drugs.
The Academy is a member of the NIC Board which was set up in 2012 to identify barriers to the implementation of NICE guidance, to ensure patients get quick, consistent access to approved treatments.